Home・Listă Acțiuni・CareDx Inc

CareDx Inc

Închisă

SectorSănătate

49.48 -5.5

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

49.38

Maxim

52.36

Indicatori cheie
By Trading Economics
Venit	108M 111M
Vânzări	14M 132M
P/E Medie Sector	23.399 57.366
EPS	0.17
Marjă de profit	83.848
Angajați	761
EBITDA	-3.8M 4.3M

Recomandări
By TipRanks
Recomandări	Cumpărare
Prognoză pe 12 luni	-8.8% downside

Dividende
By Acuity
Următoarele câștiguri	3 nov. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	579M 2.5B
Deschiderea anterioară	54.98
Închiderea anterioară	49.48

Sentimentul știrilor

By Acuity

50%

126 / 340 Clasament în Healthcare

CareDx Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

28 aug. 2026, 23:56 UTC

CareDx Inc shares are higher in after-market hours, reflecting a generally strong performance backdrop amid rising market expectations for a potential interest rate hike.

27 aug. 2026, 19:51 UTC

Shares of CareDx Inc. are advancing amid unusually high trading volume. Earlier in the session, shares pulled back from a session high.

26 aug. 2026, 20:08 UTC

CareDx Inc shares are higher today, regaining momentum after earlier pulling back. The broader market reflects mixed performance amid recent inflation data.

25 aug. 2026, 20:07 UTC

CareDx Inc. shares are higher today, reflecting a strong upward move since Monday amid easing Treasury yields that support equities and investor sentiment.

24 aug. 2026, 19:26 UTC

Social Media

CareDx Inc shares are lower today, despite social media discussions projecting a price target of $75 by 2027 and expected revenues of $575 million.

21 aug. 2026, 23:01 UTC

CareDx Inc shares are higher in after-market trading, reflecting notable activity despite broader market volatility and no specific company news identified.

20 aug. 2026, 20:06 UTC

CareDx Inc. shares are higher, recovering from an earlier pullback, amid rising crude oil prices and increased U.S. Treasury yields influencing market dynamics.

19 aug. 2026, 23:56 UTC

CareDx Inc shares are higher in after-market hours, remaining above their 20-day moving average. No specific news was identified to explain the movement.

18 aug. 2026, 20:04 UTC

CareDx Inc shares are lower today, reflecting broader market trends amid rising U.S. Treasury yields and inflation concerns. The stock remains down since Monday's close.

14 aug. 2026, 20:02 UTC

CareDx Inc shares are lower today amid notable volatility. A recent report showed an unexpected drop in U.S. retail sales, impacting broader market sentiment.

12 aug. 2026, 19:36 UTC

CareDx Inc. shares are lower today, reflecting a slight decline since Tuesday's close, despite earlier rebounding from a session low.

11 aug. 2026, 23:41 UTC

CareDx Inc shares advanced in after-market trading, reflecting notable gains since Tuesday's close. The stock remains well above its 20-day moving average.

10 aug. 2026, 23:46 UTC

CareDx Inc shares are higher in after-market hours, trading significantly above their 20-day moving average and near the upper end of their one-month range.

7 aug. 2026, 20:06 UTC

CareDx Inc shares are higher today, recovering from an early dip. The stock has gained significantly since Thursday amid a decline in Treasury yields.

5 aug. 2026, 19:46 UTC

Shares of CareDx Inc. are lower today amid unusual volatility, reflecting a broader market sentiment influenced by disappointing employment data from ADP.

4 aug. 2026, 21:36 UTC

CareDx Inc shares are higher in after-market trading, reflecting a broader U.S. stock rally amid declining crude oil prices easing inflation concerns.

3 aug. 2026, 20:02 UTC

News

CareDx Inc shares rise following a rating upgrade to Buy from Craig-Hallum and a new price target of $64, up from $35.

31 iul. 2026, 23:06 UTC

News

CareDx shares are lower in after-market hours despite a 52% revenue increase to $132 million and raised full-year guidance to $490 million-$500 million.

30 iul. 2026, 23:41 UTC

News

CareDx Inc reported second-quarter revenue of $132 million, exceeding estimates. Following strong results and raised guidance, shares are higher in after-market trading.

29 iul. 2026, 19:56 UTC

CareDx Inc shares are lower, continuing a six-session decline amid rising crude oil prices and inflation concerns affecting broader market sentiment.

27 iul. 2026, 19:16 UTC

News

CareDx Inc is trading lower today, reflecting broader market trends amid declining oil prices and easing geopolitical tensions ahead of the Federal Reserve meeting.

22 iul. 2026, 19:16 UTC

CareDx Inc shares are lower today with no specific news identified. Broader market sentiment is affected by rising crude oil prices amid geopolitical tensions.

20 iul. 2026, 18:53 UTC

News

CareDx shares are lower as Director Valantine Hannah sold 28,779 shares at prices between $36.14 and $36.55, raising investor concerns.

Comparație

Modificare preț

CareDx Inc Așteptări

Obiectiv de preț

By TipRanks

-8.8% jos

Prognoză pe 12 luni

Medie 47.75 USD -8.8%

Maxim 64 USD

Minim 21 USD

În baza a 5 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruCareDx Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

5 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 5 analiști care au acordat evaluări ale acțiunilor CareDx Inc - Dist în ultimele 3 luni.

Sentiment

By Acuity

126 / 340 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre CareDx Inc

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.